ATP1B3 Restricts Hepatitis B Virus Replication Via Reducing the Expression of the Envelope Proteins

Jun Zhang1, Tianhang Zheng1, Xiaolei Zhou1

  • 1Institute of Virology and AIDS Research, the First Hospital of Jilin University, Changchun, 130021, China.

Virologica Sinica
|February 3, 2021
PubMed

Insights

ATP1B3 protein degrades hepatitis B virus (HBV) envelope proteins via the proteasome pathway, offering a new therapeutic target for HBV infection.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • ATP1B3 was previously shown to inhibit hepatitis B virus (HBV) replication through NF-κB activation.
  • Mutant ATP1B3 proteins, despite lacking NF-κB activation, still suppressed HBV replication, indicating an alternative mechanism.
  • This study investigates the uncharacterized pathway of ATP1B3-mediated HBV suppression.

Purpose of the Study:

  • To elucidate the novel mechanism by which ATP1B3 suppresses HBV replication.
  • To investigate the role of ATP1B3 in the degradation of HBV envelope proteins.
  • To explore the potential of ATP1B3 as a therapeutic target for HBV infection.

Main Methods:

  • Western blotting to assess HBV envelope protein expression.
  • Proteasome inhibitor MG132 treatment to evaluate protein degradation pathways.
  • Co-immunoprecipitation (Co-IP) assays to detect protein interactions and ubiquitination.
  • Immunofluorescence microscopy for co-localization studies.

Main Results:

  • ATP1B3 significantly reduced the expression of HBV envelope proteins (LHBs, MHBs, SHBs).
  • Proteasome inhibition by MG132 rescued the degradation of envelope proteins, implicating the proteasome pathway.
  • ATP1B3 was found to interact with and induce polyubiquitination of LHBs and MHBs.
  • Co-localization of ATP1B3 with LHBs and MHBs was confirmed.

Conclusions:

  • ATP1B3 suppresses HBV replication by promoting the proteasome-dependent degradation of HBV envelope proteins.
  • ATP1B3 interacts with and polyubiquitinates HBV envelope proteins, marking them for degradation.
  • Targeting ATP1B3 presents a promising therapeutic strategy for managing HBV infection.

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
393
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.9K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.4K